These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4146364)

  • 1. The role of ABO blood groups in blood rheology of cardiovascular disorders.
    Dintenfass L
    Angiology; 1973; 24(7):442-53. PubMed ID: 4146364
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of ABO blood groups in dynamic coagulation and thrombus formation in vascular disease. An in vitro study.
    Dintenfass L
    Haematologia (Budap); 1971; 5(3):205-16. PubMed ID: 5128745
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical rheology in cardiovascular disease.
    Chien S
    Bibl Anat; 1977; (16 Pt 2):472-4. PubMed ID: 603586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood rheology as diagnostic and predictive tool in cardiovascular diseases. Effect of ABO blood groups.
    Dintenfass L
    Angiology; 1974 Jun; 25(6):365-72. PubMed ID: 4841852
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of the Russian alpha-adrenergic blockader tropafen on the coagulative and rheological properties of the blood in patients with acute myocardial infarction].
    Zabelin IV; Solov'ev VV; Barinov VG; Evdokimov VV; Shvedova LP
    Kardiologiia; 1988 Apr; 28(4):89-90. PubMed ID: 2899178
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of ABO blood groups and fibrinogen on thrombus formation and aggregation of red cells in cardiovascular and malignant diseases: new aspects of biorheological characterization of disease.
    Dintenfass L; Stewart JH; Milton GW; Forbes CD
    Biorheology; 1973 Dec; 10(4):585-94. PubMed ID: 4593440
    [No Abstract]   [Full Text] [Related]  

  • 7. Practical clinical pharmacology of antihypertensive drugs.
    Gifford RW
    Cardiovasc Clin; 1975; 7(1):143-56. PubMed ID: 238740
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemorheological tests in subjects with vascular diseases and post-infarction patients treated with platelet aggregation inhibitors].
    Cortinovis A; Crippa A; Compagnoni GC; Fioravanti C
    Cardiologia; 1983 Apr; 28(4):315-25. PubMed ID: 6146323
    [No Abstract]   [Full Text] [Related]  

  • 9. The rheological effects of cinnarizine and flunarizine in normal and pathologic conditions.
    De Cree J; De Cock W; Geukens H; De Clerck F; Beerens M; Verhaegen H
    Angiology; 1979 Aug; 30(8):505-15. PubMed ID: 380411
    [No Abstract]   [Full Text] [Related]  

  • 10. Dynamic blood coagulation, thrombus formation and degradation in patients with peripheral vascular disease (arteriosclerosis, including diabetic): an in vitro study.
    Ditenfass L; Sharp A
    Ann Surg; 1969 Dec; 170(6):984-95. PubMed ID: 5352651
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of antihypertensive agents on serum lipids and lipoproteins.
    Lardinois CK; Neuman SL
    Arch Intern Med; 1988 Jun; 148(6):1280-8. PubMed ID: 2897834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of molsidomine on rheological parameters and the incidence of cardiovascular events].
    Wöhrle J; Nusser T; Hoffmeister A; Kestler HA; Grebe OC; Höher M; Hombach V; Koenig W; Kochs M
    Dtsch Med Wochenschr; 2003 Jun; 128(24):1333-7. PubMed ID: 12802741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacology of hypotensive substances].
    Chekman LS; Tumanov VA
    Farm Zh; 1974; 29(3):69-73. PubMed ID: 4152209
    [No Abstract]   [Full Text] [Related]  

  • 14. beta-Thromboglobulin--a specific marker of in-vivo platelet release reaction.
    Zahavi J; Kakkar VV
    Thromb Haemost; 1980 Aug; 44(1):23-9. PubMed ID: 6158764
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of carvedilol on serum lipids in patients with essential hypertension.
    Goto Y; Tamachi H; Fusegawa Y; Nakaya N; Homma Y; Mikami M; Iori S; Yamazaki A
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S45-50. PubMed ID: 1721979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic value of the thrombelastogram (TEG) in arteriosclerosis and hypertension disease].
    Amanasob K
    Folia Med (Plovdiv); 1969; 11(2):150-5. PubMed ID: 4988575
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanism of action and adverse effect of antihypertensive agents and their countermeasures].
    Hiwada K
    Nihon Naika Gakkai Zasshi; 1990 Jan; 79(1):48-53. PubMed ID: 1969894
    [No Abstract]   [Full Text] [Related]  

  • 18. ABO blood group distribution and major cardiovascular risk factors in patients with acute myocardial infarction.
    Sari I; Ozer O; Davutoglu V; Gorgulu S; Eren M; Aksoy M
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):231-4. PubMed ID: 18388504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rheological and coagulative aspects of using nitroglycerin in the acute period of myocardial infarct].
    Zabelin IV; Solov'ev VV; Barinov VG; Evdokimov VV; Shvedova LP
    Kardiologiia; 1987 Oct; 27(10):121-2. PubMed ID: 3121903
    [No Abstract]   [Full Text] [Related]  

  • 20. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
    Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
    JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.